Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure
Open Access
- 1 May 2002
- journal article
- Published by Wiley in Clinical Cardiology
- Vol. 25 (5) , 247-249
- https://doi.org/10.1002/clc.4950250512
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Benefit of β-blockers for heart failure: proven in 1999The Lancet, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Clinical Effects of β-Adrenergic Blockade in Chronic Heart FailureCirculation, 1998
- Safety and efficacy of carvedilol in severe heart failureJournal of Cardiac Failure, 1997
- Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart diseaseThe Lancet, 1997
- Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart FailureCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Guidelines for the Evaluation and Management of Heart FailureJournal of the American College of Cardiology, 1995